Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA
Journal
Overview
Identity
View All
Overview
publication venue for
Follow-on osteoporosis therapy after denosumab discontinuation among Medicare beneficiaries.
2025
The rise and fall of raloxifene use for osteoporosis, 1999-2022. .
36:1277-1286.
2025
Osteoporosis medication use over time in the United States and Canada. .
36:1089-1094.
2025
Sex-specific associations of vitamin D and bone biomarkers with bone density and physical function during recovery from hip fracture: the Baltimore Hip Studies. .
36:855-863.
2025
Association of bone fracture with 30-year body mass index (BMI) trajectories: findings from the Framingham Heart Study : Bone fracture and 30-year BMI trajectories. .
35:1205-1212.
2024
Deprescribing bisphosphonates for older adults with dementia: perspectives of caregivers. .
35:589-598.
2023
Metabolic factors associated with incident fracture among older adults with type 2 diabetes mellitus: a nested case-control study. .
34:1263-1268.
2023
Long-term outcome collection after hip fracture in Ireland: a systematic review of traditional and grey literature. .
34:1179-1191.
2023
National trends in osteoporosis medication use among Medicare beneficiaries with and without Alzheimer's disease/related dementias. .
34:725-733.
2023
Association of covert brain infarcts and white matter hyperintensities with risk of hip fracture in older adults: the Cardiovascular Health Study. .
34:91-99.
2022
Osteoporosis identification among previously undiagnosed individuals with vertebral fractures. .
33:1925-1935.
2022
Associations of components of sarcopenia with risk of fracture in the Osteoporotic Fractures in Men (MrOS) study. .
33:1815-1821.
2022
The association of frailty with clinical and economic outcomes among hospitalized older adults with hip fracture surgery. .
33:1477-1484.
2022
Bisphosphonate holidays: using cost-effectiveness analysis for the "yes, but" questions. .
32:2389-2390.
2021
Patterns of oral bisphosphonate deprescribing in older nursing home residents with dementia. .
33:379-390.
2021
Zoledronic acid and bone health in older adults with cognitive impairment. .
33:293-298.
2021
Zoledronic acid reduces the rate of clinical fractures after surgical repair of a hip fracture regardless of the Pretreatment bone mineral density. .
32:1217-1219.
2021
COVID-19 and effects on osteoporosis management: the patient perspective from a National Osteoporosis Foundation survey. .
32:619-622.
2021
How has COVID-19 affected the treatment of osteoporosis? An IOF-NOF-ESCEO global survey. .
32:611-617.
2021
Comparative effectiveness of denosumab, teriparatide, and zoledronic acid among frail older adults: a retrospective cohort study. .
32:565-573.
2021
Over half of seniors who start oral bisphosphonate therapy are exposed for 3 or more years: novel rolling window approach and patterns of use. .
32:1413-1420.
2021
FRAX without BMD can be used to risk-stratify Veterans who recently sustained a low trauma non-vertebral/non-hip fracture. .
32:467-472.
2020
Identification of non-Hodgkin lymphoma patients at risk for treatment-related vertebral density loss and fractures. .
32:281-291.
2020
Factors associated with the contemplative stage of readiness to initiate osteoporosis treatment. .
31:1283-1290.
2020
Physiotherapy rehabilitation for osteoporotic vertebral fracture-a randomised controlled trial and economic evaluation (PROVE trial). .
31:277-289.
2019
Bisphosphonate drug holidays. .
30:-.
2019
Time trends in oral bisphosphonate initiation in Ontario, Canada over 20 years reflect drug policy and healthcare delivery changes. .
30:2311-2319.
2019
A systematic review and meta-analysis of the effect of bisphosphonate drug holidays on bone mineral density and osteoporotic fracture risk. .
30:705-720.
2019
Prediction of incident vertebral fracture using CT-based finite element analysis. .
30:323-331.
2018
Impact of prescription drugs on second fragility fractures among US Medicare patients. .
29:2771-2779.
2018
Population-based study of age- and sex-related differences in muscle density and size in thoracic and lumbar spine: the Framingham study. .
29:1569-1580.
2018
Implementing a fracture liaison service open model of care utilizing a cloud-based tool. .
29:953-960.
2018
Teriparatide for treatment of patients with bisphosphonate-associated atypical fracture of the femur. .
29:501-506.
2017
Administrative health data: guilty until proven innocent. Response to comments by Levy and Sobolev. .
29:255-256.
2017
Self-perception of fracture risk: what can it tell us? .
28:3495-3500.
2017
Targeted spine strengthening exercise and posture training program to reduce hyperkyphosis in older adults: results from the study of hyperkyphosis, exercise, and function (SHEAF) randomized controlled trial. .
28:2831-2841.
2017
Defining hip fracture with claims data: outpatient and provider claims matter. .
28:2233-2237.
2017
The skeletal impact of the chemotherapeutic agent etoposide. .
28:2321-2333.
2017
Vitamin D deficiency is associated with functional decline and falls in frail elderly women despite supplementation. .
28:1347-1353.
2016
Second fractures among older adults in the year following hip, shoulder, or wrist fracture. .
27:2207-2215.
2016
Early effects of parathyroid hormone on bisphosphonate/steroid-associated compromised osseous wound healing. .
25:1141-50.
2013
The associations between QCT-based vertebral bone measurements and prevalent vertebral fractures depend on the spinal locations of both bone measurement and fracture. .
25:559-66.
2013
Identification of prevalent vertebral fractures using CT lateral scout views: a comparison of semi-automated quantitative vertebral morphometry and radiologist semi-quantitative grading. .
23:1007-16.
2011
Measuring health-related quality of life (HRQOL) in osteoporotic males using the Male OPAQ. .
23:841-52.
2011
The factor-of-risk biomechanical approach predicts hip fracture in men and women: the Framingham Study. .
23:513-20.
2011
Intra-and inter-reader reliability of semi-automated quantitative morphometry measurements and vertebral fracture assessment using lateral scout views from computed tomography. .
22:2677-88.
2011
Zoledronic acid results in better health-related quality of life following hip fracture: the HORIZON-Recurrent Fracture Trial. .
22:2539-49.
2011
Association between timing of zoledronic acid infusion and hip fracture healing. .
22:2329-36.
2010
Associations of APOE gene polymorphisms with bone mineral density and fracture risk: a meta-analysis. .
22:1199-209.
2010
Reliability of vertebral fracture assessment using multidetector CT lateral scout views: the Framingham Osteoporosis Study. .
22:1123-31.
2010
Does dietary protein reduce hip fracture risk in elders? The Framingham Osteoporosis Study. .
22:345-9.
2010
Application of the National Osteoporosis Foundation Guidelines to postmenopausal women and men: the Framingham Osteoporosis Study. .
21:53-60.
2010
Hip protectors: recommendations for conducting clinical trials--an international consensus statement (part II). .
21:1-10.
2010
Hip protectors: recommendations for biomechanical testing--an international consensus statement (part I). .
20:1977-88.
2009
Protective effect of total and supplemental vitamin C intake on the risk of hip fracture--a 17-year follow-up from the Framingham Osteoporosis Study. .
20:1853-61.
2009
Do physicians within the same practice setting manage osteoporosis patients similarly? Implications for implementation research. .
20:1921-7.
2009
Hip and other osteoporotic fractures increase the risk of subsequent fractures in nursing home residents. .
19:1225-33.
2008
Prevalence and predictors of osteoporosis treatment in nursing home residents with known osteoporosis or recent fracture. .
18:553-9.
2006
Reduction in the risk of developing back pain persists at least 30 months after discontinuation of teriparatide treatment: a meta-analysis. .
17:1630-7.
2006
Association of dietary and biochemical measures of vitamin K with quantitative ultrasound of the heel in men and women. .
17:600-7.
2006
Reduced risk of back pain following teriparatide treatment: a meta-analysis. .
17:273-80.
2005
Vertebral deformity, back symptoms, and functional limitations among older women: the Framingham Study. .
16:1086-95.
2005
Establishing the compliance in elderly women for use of a low level mechanical stress device in a clinical osteoporosis study. .
15:918-26.
2004
The contribution of hip fracture to risk of subsequent fractures: data from two longitudinal studies. .
14:879-83.
2003
Risk factors for hip fracture in skilled nursing facilities: who should be evaluated? .
14:484-9.
2003
Can historical and functional risk factors be used to predict fractures in community-dwelling older adults? development and validation of a clinical tool. .
13:955-61.
2002
The effect of smoking at different life stages on bone mineral density in elderly men and women. .
6:240-8.
1996
What information can the lay public find about osteoporosis treatment? A descriptive study coding the content and quality of bisphosphonate information on the internet
2019
Identity
International Standard Serial Number (ISSN)
